These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31550607)

  • 1. Replication of HIV-1 envelope protein cytoplasmic domain variants in permissive and restrictive cells.
    Staubus AO; Alfadhli A; Barklis RL; Barklis E
    Virology; 2019 Dec; 538():1-10. PubMed ID: 31550607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
    Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-molecule imaging of HIV-1 envelope glycoprotein dynamics and Gag lattice association exposes determinants responsible for virus incorporation.
    Pezeshkian N; Groves NS; van Engelenburg SB
    Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25269-25277. PubMed ID: 31757854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.
    Alfadhli A; Mack A; Ritchie C; Cylinder I; Harper L; Tedbury PR; Freed EO; Barklis E
    J Virol; 2016 Jun; 90(12):5657-5664. PubMed ID: 27030269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions.
    Alfadhli A; Staubus AO; Tedbury PR; Novikova M; Freed EO; Barklis E
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles.
    Brandano L; Stevenson M
    J Virol; 2012 Feb; 86(4):2347-59. PubMed ID: 22156517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second site reversion of HIV-1 envelope protein baseplate mutations maps to the matrix protein.
    Alfadhli A; Romanaggi C; Barklis RL; Barklis E
    J Virol; 2024 Feb; 98(2):e0174223. PubMed ID: 38193694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV cell-to-cell transmission requires the production of infectious virus particles and does not proceed through env-mediated fusion pores.
    Monel B; Beaumont E; Vendrame D; Schwartz O; Brand D; Mammano F
    J Virol; 2012 Apr; 86(7):3924-33. PubMed ID: 22258237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tyrosine-based motif in the HIV-1 envelope glycoprotein tail mediates cell-type- and Rab11-FIP1C-dependent incorporation into virions.
    Qi M; Chu H; Chen X; Choi J; Wen X; Hammonds J; Ding L; Hunter E; Spearman P
    Proc Natl Acad Sci U S A; 2015 Jun; 112(24):7575-80. PubMed ID: 26034275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.
    Tedbury PR; Mercredi PY; Gaines CR; Summers MF; Freed EO
    J Mol Biol; 2015 Mar; 427(6 Pt B):1413-1427. PubMed ID: 25659909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Super-resolution microscopy reveals specific recruitment of HIV-1 envelope proteins to viral assembly sites dependent on the envelope C-terminal tail.
    Muranyi W; Malkusch S; Müller B; Heilemann M; Kräusslich HG
    PLoS Pathog; 2013 Feb; 9(2):e1003198. PubMed ID: 23468635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of matrix in HIV-1 envelope glycoprotein incorporation.
    Tedbury PR; Freed EO
    Trends Microbiol; 2014 Jul; 22(7):372-8. PubMed ID: 24933691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Envelope Glycoprotein Trafficking through the Endosomal Recycling Compartment Is Required for Particle Incorporation.
    Kirschman J; Qi M; Ding L; Hammonds J; Dienger-Stambaugh K; Wang JJ; Lapierre LA; Goldenring JR; Spearman P
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29212940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maturation of the matrix and viral membrane of HIV-1.
    Qu K; Ke Z; Zila V; Anders-Össwein M; Glass B; Mücksch F; Müller R; Schultz C; Müller B; Kräusslich HG; Briggs JAG
    Science; 2021 Aug; 373(6555):700-704. PubMed ID: 34353956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virion-incorporated PSGL-1 and CD43 inhibit both cell-free infection and transinfection of HIV-1 by preventing virus-cell binding.
    Murakami T; Carmona N; Ono A
    Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8055-8063. PubMed ID: 32193343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the HIV entry, assembly and release pathways for anti-HIV gene therapy.
    Joshi A; Garg H; Ablan S; Freed EO; Nagashima K; Manjunath N; Shankar P
    Virology; 2011 Jul; 415(2):95-106. PubMed ID: 21529874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly.
    Lambelé M; Labrosse B; Roch E; Moreau A; Verrier B; Barin F; Roingeard P; Mammano F; Brand D
    J Virol; 2007 Jan; 81(1):125-40. PubMed ID: 17050592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Envelope glycoprotein mobility on HIV-1 particles depends on the virus maturation state.
    Chojnacki J; Waithe D; Carravilla P; Huarte N; Galiani S; Enderlein J; Eggeling C
    Nat Commun; 2017 Sep; 8(1):545. PubMed ID: 28916807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical evidence of a role for matrix trimerization in HIV-1 envelope glycoprotein incorporation.
    Tedbury PR; Novikova M; Ablan SD; Freed EO
    Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E182-90. PubMed ID: 26711999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation.
    Murphy RE; Saad JS
    Viruses; 2020 May; 12(5):. PubMed ID: 32429351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.